Why Krystal Biotech, Inc. (KRYS) stock fell 10.9% on Monday, November 2, 2026

Krystal Biotech, Inc. (KRYS) closed at $295.9, down 10.95% on Monday, November 2, 2026, on volume of 1,198,521 shares (4.4× its 3-month average); market value about $8.80B.

What happened: primary sources

Events Nexqual found for KRYS on Monday, November 2, 2026 or the trading day before (October 30, 2026):

These are listed as context. A filing or rating change on the same day is not proof that it caused the move; read the source.

More on KRYS

KRYS stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Earnings report: KRYS results, November 2, 2026. Other big moves that day: November 2, 2026.

Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built November 4, 2026 at 10:48 UTC. Not investment advice.

Data source: Nexqual. Last updated: November 4, 2026 at 10:48 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt